James G Marks, Donald V Belsito, Vincent A DeLeo, Joseph F Fowler, Anthony F Fransway, Howard I Maibach, C G Toby Mathias, Melanie D Pratt, Robert L Rietschel, Elizabeth F Sherertz, Frances J Storrs, James S Taylor
{"title":"North American Contact Dermatitis Group patch-test results, 1998 to 2000.","authors":"James G Marks, Donald V Belsito, Vincent A DeLeo, Joseph F Fowler, Anthony F Fransway, Howard I Maibach, C G Toby Mathias, Melanie D Pratt, Robert L Rietschel, Elizabeth F Sherertz, Frances J Storrs, James S Taylor","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patch testing is the most worthwhile diagnostic tool for the evaluation of patients with suspected allergic contact dermatitis.</p><p><strong>Objective: </strong>This study reports patch-testing results from July 1, 1998, to December 31, 2000, by the North American Contact Dermatitis Group.</p><p><strong>Methods: </strong>Patients were tested with the same screening series of allergens, using a standardized patch-testing technique. The data from these patients were recorded on a standard computer entry form and analyzed.</p><p><strong>Results: </strong>Fifty allergens were tested on over 5,800 patients. Amidoamine, benzophenone-3, and iodopropynyl butylcarbamate were the new allergens. The top 10 allergens in frequency of positive reactions were identical to those of our 1996-to 1998-study period. The incidence of allergic nickel reactions continues to go up, leading all the test substances by 16.2%.</p><p><strong>Conclusion: </strong>Our findings reinforce the need for a more comprehensive group of diagnostic allergens than is found in the T.R.U.E. TEST, which is sold in the United States.</p>","PeriodicalId":7612,"journal":{"name":"American journal of contact dermatitis : official journal of the American Contact Dermatitis Society","volume":"14 2","pages":"59-62"},"PeriodicalIF":0.0000,"publicationDate":"2003-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of contact dermatitis : official journal of the American Contact Dermatitis Society","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Patch testing is the most worthwhile diagnostic tool for the evaluation of patients with suspected allergic contact dermatitis.
Objective: This study reports patch-testing results from July 1, 1998, to December 31, 2000, by the North American Contact Dermatitis Group.
Methods: Patients were tested with the same screening series of allergens, using a standardized patch-testing technique. The data from these patients were recorded on a standard computer entry form and analyzed.
Results: Fifty allergens were tested on over 5,800 patients. Amidoamine, benzophenone-3, and iodopropynyl butylcarbamate were the new allergens. The top 10 allergens in frequency of positive reactions were identical to those of our 1996-to 1998-study period. The incidence of allergic nickel reactions continues to go up, leading all the test substances by 16.2%.
Conclusion: Our findings reinforce the need for a more comprehensive group of diagnostic allergens than is found in the T.R.U.E. TEST, which is sold in the United States.